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heckpoints maintain order and ﬁdelity in the cell cy-
cle by blocking late-occurring events when earlier
events are improperly executed. Here we describe
evidence for the participation of Chk1 in an intra-S phase
checkpoint in mammalian cells. We show that both Chk1
and Chk2 are phosphorylated and activated in a caffeine-
 
sensitive signaling pathway during S phase, but only in
response to replication blocks, not during normal S phase
progression. Replication block–induced activation of Chk1
and Chk2 occurs normally in ataxia telangiectasia (AT)
C
 
cells, which are deﬁcient in the S phase response to ionizing
radiation (IR). Resumption of synthesis after removal of rep-
lication blocks correlates with the inactivation of Chk1 but
not Chk2. Using a selective small molecule inhibitor, cells
 
lacking Chk1 function show a progressive change in the
global pattern of replication origin ﬁring in the absence of
any DNA replication. Thus, Chk1 is apparently necessary for
an intra-S phase checkpoint, ensuring that activation of late
replication origins is blocked and arrested replication fork
integrity is maintained when DNA synthesis is inhibited.
 
Introduction
 
In eukaryotic cells, fidelity of chromosome transmission is
maintained by checkpoints that prevent cell cycle progres-
sion if chromosomes are damaged, remain unreplicated, or
are incorrectly segregated. Checkpoints responding to DNA
damage or incomplete DNA replication elicit one cellular
response by inhibiting cyclin-dependent kinases that drive
cell cycle progression (Nurse, 1997; Weinert, 1998). In
yeasts, a group of six checkpoint proteins monitors the pres-
ence of DNA damage or incomplete DNA replication and
signals to components of the cell cycle machinery (Weinert,
1998). Signaling elements of this pathway include Rad3
(Bentley et al., 1996), a phosphatidylinositol 3-kinase–like
 
kinase, as well as downstream protein kinases Chk1 (Walworth
et al., 1993) and Cds1 (Murakami and Okayama, 1995),
which are believed to directly interact with effectors of cell
cycle progression (Furnari et al., 1997; Boddy et al., 1998;
Zeng et al., 1998).
These gene products have structural and functional equiv-
 
alents in mammalian cells. Upstream signaling elements
include the phosphatidylinositol 3-kinase family members
ataxia telangiectasia mutated (ATM)* (Savitsky et al., 1995)
and ATM- and Rad3-related protein (ATR) (Bentley et al.,
1996; Cimprich et al., 1996). Mammalian Chk1 is a ho-
mologue of yeast Chk1 (Sanchez et al., 1997), whereas
 
Chk2/hCds1 (Matsuoka et al., 1998; Brown et al., 1999; Chat-
 
urvedi et al., 1999) is a homologue of 
 
Schizosaccharomyces
pombe
 
 Cds1 (
 
S. cerevisiae
 
 Rad53). Chk1 and Chk2 act
downstream of ATM and ATR to elicit appropriate responses
such as cell cycle arrest (Peng et al., 1997; Sanchez et al.,
1997; Matsuoka et al., 1998; Liu et al., 2000).
 
In eukaryotes, DNA replication is initiated from many
origins (Cairns, 1966; Huberman and Riggs, 1968) that fire
in precise temporal sequence throughout S phase (Diffley,
1998). In budding yeast, when replication is blocked, late-
firing origins are prevented from initiating replication (San-
tocanale and Diffley, 1998; Shirahige et al., 1998) and entry
into mitosis is inhibited (Weinert et al., 1994). These cell
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cycle blocks are mediated by Rad53 and Mec1 (Weinert et
al., 1994; Santocanale and Diffley, 1998; Shirahige et al.,
1998; Santocanale et al., 1999).
 
In mammalian cells, several S phase checkpoint responses
have been described. Fusion of S phase HeLa cells with late
G2 cells results in a delay in appearance of mitotic forms,
suggesting that ongoing DNA synthesis generates a check-
point signal (Rao and Johnson, 1970). DNA damage in-
curred in S phase causes inhibition of replication initiation
and chain elongation (Painter and Young, 1980). Such inhi-
bition is dramatically reduced in cells from AT patients, indi-
cating a role for the ATM kinase in mediating this response
(Painter and Young, 1980). The roles of ATR, Chk1, and
Chk2 in mammalian S phase checkpoints are much less clear,
in part because ATR (Brown and Baltimore, 2000; de Klein
et al., 2000) and Chk1 (Liu et al., 2000) are essential genes.
In mammalian cells, the timing of origin firing may be ex-
amined by monitoring the dynamics of groups of coordi-
nately replicated chromosomal domains. The origin firing
program operates independently of checkpoint pathways but
is sensitive to them nonetheless (Dimitrova and Gilbert,
2000). Whenever cells are prevented from completing syn-
thesis from early replicons, a caffeine-sensitive, ATM-inde-
pendent, intra-S phase checkpoint stabilizes components of
existing replicons and prevents initiation of replication from
late-firing origins (Dimitrova and Gilbert, 2000).
Here, we have investigated the properties of Chk1 and
Chk2 during S phase in mammalian cells. We present data
to suggest that Chk1 responds to stalled replication forks as
a necessary component for an intra-S phase checkpoint, en-
suring that activation of late replication origins is blocked
when synthesis from early origins is inhibited.
 
Results
 
Specific S phase activation of Chk1 in mammalian cell
 
s
 
Anti-Chk1 antibodies specifically recognized a single protein
in HeLa (Fig. 1 A) and other mammalian cell lysates (un-
published data), which migrated with an apparent 
 
M
 
r
 
 of
 
 
 
58 kD, as expected (Sanchez et al., 1997). Anti-Chk1 im-
munoprecipitates (IPs) contained kinase activity that effi-
ciently phosphorylated a peptide derived from Cdc25C (Fig.
1 B) and containing Ser216, which is phosphorylated in vivo
and in vitro by Chk1 (Peng et al., 1997; Sanchez et al.,
1997). IP kinase activity was completely inhibited by submi-
cromolar concentrations of UCN-01 (Fig. 1 B), shown pre-
viously to be a selective small molecule inhibitor of Chk1
(Graves et al., 2000).
Next, we compared kinase activity of Chk1 and Chk2 in
IPs from lysates of cells treated either with hydroxyurea
(HU), which arrests cells in or at the start of S phase, or with
10 Gy of ionizing radiation (IR), which arrests cells in G2.
Chk1 was specifically activated 3.5–4-fold in cells arrested in
S phase compared with asynchronous cell controls (Fig. 1
C). No significant activation was observed in response to IR.
Activation was accompanied by conversion of Chk1 to a
number of forms migrating with reduced mobility on SDS-
PAGE (Fig. 1 D). Both activation and mobility shift of
Chk1 were reversed by protein phosphatase 2A treatment
(unpublished data), indicating that both were due to phos-
phorylation. The absence of Chk1 activation after IR was
not due to an absence of a response in these cells to IR, be-
cause this treatment gave rise to robust phosphorylation and
activation of Chk2 kinase (Fig. 1, E and F, and unpublished
data), which was also activated by HU treatment as expected
(Matsuoka et al., 1998; Chaturvedi et al., 1999).
Several checkpoints are sensitive to caffeine, resulting in
inappropriate cell cycle progression (Busse et al., 1978;
Schlegel and Pardee, 1986). Likely in vivo targets of caffeine
are ATM (Blasina et al., 1999) and ATR (Hall-Jackson et
Figure 1. Chk1 and Chk2 activation in response to HU and IR. (A) 
HeLa cell lysate (50  g) subjected to SDS-PAGE and immunoblot-
ted with anti-Chk1 antibodies. (B) Kinase assays in the presence of 
indicated concentrations of UCN-01 performed on Chk1 IPs from 
HeLa cell lysates. (C) HeLa cells   caffeine (5 mM), were treated 
with hydroxyurea ( HU, 2 mM) or irradiated (10 Gy,  IR) as 
indicated. Cells were harvested, lysed and Chk1 IP kinase assays 
performed. (D) Lysates from cells treated as in C were subjected to 
SDS-PAGE and immunoblotted for Chk1. (E) Kinase assays 
performed on Chk2 IPs from lysates obtained as in C. (F) Immuno-
blot analysis of Chk2 following treatments indicated in E. 
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al., 1999). Caffeine completely abrogated phosphorylation
and activation of Chk1 induced by S phase arrest (Fig. 1, C
and D), as well as activation of Chk2 in response to HU or
IR (Fig. 1, E and F).
 
S phase activation of checkpoint proteins Chk1 and 
Chk2 does not require ATM
 
Cells derived from patients with AT are defective in some
(Houldsworth and Lavin, 1980; Painter and Young, 1980),
but not all (Dimitrova and Gilbert, 2000), S phase check-
points. We utilized ATM-null cells (AT221JE-T) trans-
fected either with empty vector or vector encoding wild-type
ATM (Ziv et al., 1997) to determine whether S phase activa-
tion of Chk1, as well as Chk2, required ATM. Both Chk1
(Fig. 2, A and B) and Chk2 (Fig. 2, C and D) were phos-
phorylated and activated in response to HU, to levels very
similar to those observed with other cell types. Reintroduc-
 
tion of wild-type ATM had little or no effect on the extent
of activation in response to HU (unpublished data). As ex-
pected, treating ATM-null cells with 10 Gy of IR had no ef-
fect on either Chk1 or Chk2 activity (Matsuoka et al.,
1998). Surprisingly, we also found that reintroduction of
ATM had a very small effect on the phosphorylation and ac-
tivation of Chk1 (Fig. 2, E and F) compared with the re-
sponse to HU. Cells expressing ATM had slightly higher
basal levels of Chk1 activity compared with ATM-null cells,
and IR treatment in the presence of ATM led to hyperphos-
phorylation of a very small fraction of Chk1 in these cells
(Fig. 2 F). This was not because these cells are refractory to
IR under these conditions, as reintroduction of ATM rees-
tablished the phosphorylation and activation of Chk2 after
IR (Fig. 2, G and H).
These results indicate that both Chk1 and Chk2 are activated
in S phase cells in a caffeine-sensitive manner that does not re-
quire ATM. They also show that although Chk1 has been im-
plicated in the G2 checkpoint responding to IR, the fraction of
Chk1 phosphorylated and activated is substantially less than
that observed for these cells in S phase. This suggests that in ad-
dition to a role in G2 arrest in response to IR, Chk1 plays some
role in S phase checkpoint responses in mammalian cells.
 
Arrest of DNA replication is required for S phase 
activation of Chk1 and Chk2
 
To test whether activation of Chk1 and Chk2 occurred dur-
ing normal S phase progression, we synchronized HeLa cells
in metaphase using nocodazole and mitotic shake-off. Mi-
totic cells were released into fresh medium in the presence or
absence of HU. Cells were pulse labeled with BrdU 0.5 h
before harvest, and then processed either for analysis by flow
cytometry or for lysis and characterization of Chk1 and
Chk2 proteins by IP kinase assay and immunoblot.
In the absence of HU, synchronized cells underwent nor-
mal progression through S phase over an 
 
 
 
10-h time pe-
riod, with 24% cells emerging in G2 21 h after release from
the nocodazole block (Fig. 3, A and B). In contrast, cells in
HU-containing medium entered S phase as judged by
pulsed BrdU incorporation (unpublished data), but re-
mained arrested with a G1 DNA content for the duration of
the experiment (Fig. 3, C and D). Kinase activity together
with the phosphorylation status of both Chk1 and Chk2
were analyzed every 2 h from 9 to 21 h after release from no-
codazole block. No activation or phosphorylation of Chk1
was observed during normal S phase progression, despite the
fact that 70–80% of the cells were in S phase 13–18 h after
release (Fig. 3, E and F). In contrast, cells arrested in early S
phase with HU had 2.5–5-fold higher levels of Chk1 kinase
activity (black bars) compared with those undergoing nor-
mal S phase (white bars). Activation was accompanied by a
mobility shift of Chk1 on analysis by SDS-PAGE and im-
munoblotting. A similar pattern was observed with Chk2,
although Chk2 activation on S phase arrest was more mod-
est than with Chk1 (Fig. 3, G and H).
 
Distinct checkpoint kinase responses following 
reversal of S phase arrest
 
Treating cells with aphidicolin, which stalls replication forks
by directly inhibiting DNA polymerases, resulted in mobil-
Figure 2. S phase activation of Chk1 and Chk2 is independent of 
ATM. (A–D) ATM-null (AT221JE-T) cells were untreated, treated with 
HU ( HU, 2 mM) or irradiated (10 Gy,  IR) as indicated. (A) Cells 
were lysed, and kinase assays performed on Chk1 IPs. (B) Lysates 
subjected to SDS-PAGE and immunoblotted for Chk1. (C) Kinase 
assays performed on Chk2 IPs. (D) Lysates subjected to SDS-PAGE 
and immunoblotted for Chk2. (E-H) AT221JE-T cells containing either 
vector alone ( ATM) or vector expressing ATM ( ATM) were 
irradiated (10 Gy,  IR) or not as indicated, and lysates prepared. 
(E) Kinase assays performed on immunoprecipitated Chk1. (F) Lysates 
subjected to SDS-PAGE and immunoblotted for Chk1. (G) Kinase 
assays were performed on immunoprecipitated Chk2. (H) Lysates 
subjected to SDS-PAGE and immunoblotted for Chk2. 
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Figure 3. Activation of Chk1 and Chk2 requires DNA replication 
arrest. Metaphase HeLa cells collected by nocodazole treatment 
and mitotic shake-off were released into fresh medium  / HU. 
0.5 h before harvest, at indicated times after nocodazole release, 
cells were pulse labeled with BrdU, and aliquots removed for flow 
cytometry (A–D), lysis and IP kinase assays (E and H) and immuno-
blotting (F and G). (A–D) FACS
® profiles and cell cycle position are 
shown for cells maintained in the absence (-HU, A and B) and presence ( HU, C and D) of HU (2 mM). (E) Chk1 IP kinase assays performed 
on lysates from asynchronous cycling cells (AS, grey bars), cells progressing through S phase (white bars) and arrested in early S phase (black 
bars). (F) Cell lysates as in E above subjected to SDS-PAGE and immunoblotted for Chk1. (G) Cell lysates as in E above subjected to SDS-PAGE 
and immunoblotted for Chk2. (H) Chk2 IP kinase assays performed on lysates from cells as in E. 
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ity shifts and activation of Chk1 and Chk2 identical to those
observed in cells treated with HU (Fig. 4 A), which stalls
replication forks by depleting dNTP pools. To confirm that
activation of Chk1 and Chk2 occurs in response to stalled
replication forks, we allowed HU-treated AT221JE-T cells
to recover from replication arrest and measured Chk1 and
Chk2 kinase activity as a function of S phase progression.
As judged by BrdU incorporation, 
 
 
 
70% of cells released
from HU-containing medium resumed significant synthesis
within 2 h (Fig. 4 B). Release from HU resulted in rapid
(
 
 
 
0.5 h) inactivation of Chk1, as judged by decreased activ-
ity toward its peptide substrate and higher electrophoretic
mobility (Fig. 4, C and D, upper panels). In contrast, the ac-
tivity and mobility of Chk2 remained unchanged as cells ini-
tially arrested in HU resumed S phase progression (Fig. 4, C
and D, lower panels). Identical results were also obtained us-
ing aphidicolin (unpublished data). In addition, sustained
activity of Chk2 following recovery from replication block
occurred in both ATM-null cells and AT cells retransfected
with wild-type ATM. These results indicate that Chk1, but
not Chk2, becomes inactivated, with kinetics indicative of a
link between Chk1 activation and stabilization of stalled
replication complexes together with prevention of new repli-
con initiation.
 
Selective abrogation of an S phase checkpoint
signaling pathway
 
The response of Chk1 to the imposition and removal of rep-
lication blocks suggested that it might play a role in the in-
Figure 4.  Differential inactivation of Chk1 and Chk2 following release 
from replication block. (A) Asynchronously growing HeLa cells were 
treated or not for 24 h with 2 mM HU or 5 µg/ml aphidicolin and lysates 
prepared. Kinase assays were performed on immunoprecipitated Chk1 
and Chk2 (upper panels) as indicated. Lysates were subjected to
SDS-PAGE and immunoblotted for Chk1 and Chk2 (lower panels). 
(B) Asynchronously growing AT221JE-T cells expressing ATM were 
treated with 2 mM HU for 24 h, released, and at times indicated pulse 
labeled with BrdU. Cells were fixed, stained with DAPI and anti-BrdU 
antibodies, and examined by indirect immunofluorescence microscopy. 
Identical results were observed with AT cells transfected with empty 
vector (not shown). (C and D) AT221JE-T cells containing either vector 
alone ( ATM) or vector expressing ATM ( ATM) were treated for 24 h 
with HU, and then released into fresh medium. (C) At the times indicated, 
lysates were prepared, subjected to SDS-PAGE, and immunoblotted for 
Chk1 and Chk2. (D) At times indicated, Chk1 (upper panels) and Chk2 
(lower panels) IP kinase assays were performed on lysates from AT221JE-T 
cells containing vector alone (black bars) or vector expressing ATM 
(white bars) treated as above. 
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tra-S phase checkpoint that stabilizes components of existing
replicons and prevents initiation of replication from late-fir-
ing origins (Dimitrova and Gilbert, 2000). As Chk1 is an es-
sential gene in mammals (Liu et al., 2000), we utilized
UCN-01 which, at submicromolar levels, is highly selective
for Chk1 over Chk2 (Graves et al., 2000), to determine the
effect of abrogating Chk1 function. UCN-01 has been used
to demonstrate a critical role for Chk1 in the IR-induced G2
checkpoint (Graves et al., 2000), as well as the UV-induced
G1/S checkpoint (Mailand et al., 2000).
When active, mammalian Chk1 undergoes autophos-
phorylation at multiple sites (Chen et al., 2000; unpublished
data). In yeast, Chk1 appears to undergo significant auto-
phosphorylation after activation by Rad3 (Walworth and
Bernards, 1996). UCN-01 blocked Chk1 autophosphoryla-
tion in vitro (Fig. 5 A) and substantially reduced but did
not eliminate the S phase arrest–induced hyperphosphoryla-
tion of Chk1 in vivo (Fig. 5, B and E), indicating that
UCN-01 is capable of interfering with the Chk1 signaling
pathway. In contrast, a control protein kinase inhibitor,
K-252c, had no effect on Chk1 hyperphosphorylation in vivo
(unpublished data). These results suggested that, as in yeast,
some of the hyperphosphorylation of Chk1 in mammalian
cells in vivo is due to autophosphorylation, which may be
blocked by treating cells with UCN-01. To show that
UCN-01 was indeed acting on Chk1 and not by interfering
 
with a known upstream activator, ATR (Liu et al., 2000) we
investigated the effect of UCN-01 on ATR-mediated phos-
phorylation of Chk1 in vitro. UCN-01 had no effect on
phosphorylation of Chk1 by ATR (Fig. 5 D). ATR is sensi-
tive to inhibition by caffeine (Hall-Jackson et al., 1999). If
UCN-01 does indeed block Chk1 autophosphorylation but
not phosphorylation of Chk1 by its upstream activator,
then lysates from HU-arrested cells treated with UCN-01
should contain forms of Chk1 with reduced mobility com-
pared with HU-arrested cells treated with caffeine. We
found that caffeine completely blocked the mobility shift of
Chk1 in response to HU-induced replication block. In con-
trast, Chk1 from UCN-01–treated cells in HU had a re-
duced mobility, though not to the extent observed in cells
treated with HU alone (Fig. 5 E). To determine whether
UCN-01 had any effect on HU-induced Chk2 activation,
lysates from cells treated with HU 
 
 
 
/
 
 
 
UCN-01 were ana-
lyzed for Chk2. UCN-01 had no effect on either the phos-
phorylation or activation of Chk2 in response to HU treat-
ment (Fig. 5 F).
Taken together, the data in Fig. 5 indicate that in mam-
malian cells, replication arrest activates a caffeine-sensitive
pathway resulting in the phosphorylation and activation of
Chk1 and Chk2. UCN-01 acts downstream of caffeine,
blocking Chk1 function without interfering with the Chk2
pathway.
Figure 5.  UCN-01 blocks Chk1 auto-
phosphorylation in vitro and Chk1 hyper-
phosphorylation in vivo, with no effect on 
ATR kinase in vitro or S phase activation 
of Chk2 in vivo. (A) Chk1 autophosphory-
lation was measured by incorporation of 
32P from labeled ATP in the presence of 0 
(lane 1), 10 nM (lane 2) 50 nM (lane 3), 
and 300 nM UCN-01 (lane 4) followed by 
SDS-PAGE and autoradiography. (B) HeLa 
and CHO cells were treated  /  HU (2 
mM, 15 h) in the presence or absence of 
300 nM UCN-01 and lysates analyzed for 
Chk1 by SDS-PAGE and immunoblotting. 
Immunoblot is overexposed to show all 
reduced mobility forms of Chk1 on HU 
treatment. (C) SDS-PAGE and autoradiog-
raphy of kinase-dead Chk1 following its 
phosphorylation by mock (lane 1), purified 
ATR in the presence of 0 (lane 2), 0.5 ng/ l 
(lane 3), 2 ng/ l (lane 4), and 4 ng/ l DNA 
(lane 5) and (D) DNA-dependent phos-
phorylation of kinase-dead Chk1 by purified 
ATR in the presence of 0 (lane 1), 10 nM 
(lane 2) 50 nM (lane 3), and 300 nM UCN-
01 (lane 4). (E) HeLa cells treated  / HU 
as above in the presence or absence of 300 
nM UCN-01 or 5 mM caffeine, and lysates 
analyzed for Chk1 by SDS-PAGE and 
immunoblotting. Samples in lanes 1–3 are 
identical to upper panel of B but at lower 
exposure to resolve distinct forms of Chk1 
after indicated treatments. (F) HeLa cells 
treated  /  HU as above in presence or 
absence of 300 nM UCN-01 as indicated, 
were lysed and Chk2 analysed by IP kinase 
assay (upper panel) or by SDS-PAGE and 
immunoblotting (lower panel). 
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Inhibition of Chk1 function in aphidicolin-arrested 
cells results in initiation at late DNA replication origins
 
Eukaryotic chromosomes replicate from many origins pro-
grammed to initiate replication in a precise temporal se-
quence throughout S phase (Gilbert, 1986; Diffley, 1998;
Ma et al., 1998). Whenever cells are prevented from com-
pleting synthesis from early replicons, late-firing origins are
prevented from initiating replication (Hamlin, 1978; Santo-
canale and Diffley, 1998). DNA replication takes place at
discrete sites that may be visualized by pulse-labeling cells
with halogenated derivatives of deoxyuridine (dU) and
staining with fluorescently labeled antibodies specific to each
dU derivative. The spatial pattern of replication sites reveals
their temporal position within S phase, allowing the dynam-
ics of groups of coordinately replicated chromosomal do-
mains to be monitored (Dimitrova and Gilbert, 2000).
To determine whether abrogation of Chk1 function in
cells arrested in S phase would allow the initiation of replica-
tion at later-replicating sites, asynchronously growing cells
were briefly pulse labeled with CldU and then treated with
aphidicolin for 12 h. In the continued presence of aphidi-
colin, cells were incubated 
 
 
 
/
 
 
 
UCN-01 for the indicated
times. Cells were washed free of both aphidicolin and inhib-
itor, pulse labeled with IdU, and fixed and stained with
anti-CldU (green) and anti-IdU (red) antibodies. Without
UCN-01 addition, IdU labeling colocalized with CldU
throughout the 12-h incubation period, indicating that
there was no progression through S phase or initiation
Figure 6.  UCN-01 inhibits replication 
checkpoint controlling replicon firing. (A) 
Asynchronous CHOC cells were pulse 
labeled with CldU and then treated with 
aphidicolin for 12 h either in the absence 
(extreme left-hand panels,  Aphidicolin) 
or in the presence of 300 nM UCN-01. At 
time points after aphidicolin addition (0.5, 
3, 6, 9, 12 h), aliquots of cells were 
washed free of drugs, pulse labeled with 
IdU and then fixed and stained with anti-
CldU (green) and anti-IdU (red). Images 
show typical nuclei observed at indicated 
time points in cells that were prelabeled 
early, middle, or late in S phase. Blank 
panels indicate time points at which IdU 
incorporation into cells with the indicated 
CldU pattern were no longer detected, as 
these cells have progressed into G2-phase. 
(B–E) CHOC cells were synchronized at 
the G1/S boundary, and then divided into 
groups treated in parallel as follows. (B) 
Cells were either washed free of aphidi-
colin (colored circles) and allowed to 
proceed into S phase in the complete 
absence of drugs, or as controls, cells 
were maintained throughout the experi-
ment in aphidicolin alone (B, grey circles). 
(C and D) Cells were maintained in the 
continuous presence of aphidicolin in 
combination with either (C) UCN-01 or 
(D) K-252c. At the indicated times, all 
cells were washed into fresh drug-free 
medium, pulse labeled with CldU, and 
then fixed and stained with anti-CldU. The 
percentages of S phase (CldU-positive) 
nuclei showing the indicated replication 
pattern were scored at each time point. In 
addition, percentages of cells in B–D that 
incorporated CldU were also scored (E). 
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within later-replicating domains under these conditions
(Fig. 6 A, 
 
 
 
Aphidicolin). In contrast, when Chk1 function
was abrogated during the aphidicolin block by the addition
of UCN-01 for increasing lengths of time, the IdU label was
incorporated into progressively later-replicating domains,
and was accompanied by a lack of DNA synthesis from pre-
viously initiated sites. Thus, when UCN-01 was present for
only 30 min during the aphidicolin block, the majority of
signal for the two labels colocalized giving rise to mainly yel-
low foci (Fig. 6 A). However, with longer times in UCN-01
the two labels began to separate. Cells that were in early S
phase at the time of the CldU pulse (identified by the
presence of many sites of CldU incorporation distributed
throughout euchromatic compartments of the nucleus) initi-
ated replication at later-replicating euchromatic sites within
3 to 6 h and then progressed to middle-replicating sites by 6
to 9 h, and finally late-replicating heterochromatin by 12 h
after the addition of UCN-01 (Fig. 6 A, upper panels). Cells
that were in mid S phase during the CldU pulse (identified
by peripheral and peri-nucleolar CldU staining) incorpo-
rated IdU into late-replicating heterochromatin within 6 to
9 h and ceased to incorporate IdU after 12 h (Fig. 6 A, mid-
dle panels). Cells that were in late S phase during the CldU
pulse (identified by few very large sites of CldU incorpora-
tion) progressed into G2 phase within 3 to 6 h (Fig. 6 A,
lower panels). In cells that entered G2 in the absence of
DNA synthesis, nuclei underwent blebbing and fragmenta-
tion (unpublished data), possibly indicating an apoptotic re-
sponse triggered by entry of cells into G2/M phase in the
presence of an unreplicated genome, as reported previously
(Dimitrova and Gilbert, 2000).
To determine the time schedule of activation of progres-
sively later-replicating foci in cells lacking Chk1 function,
mitotic cells previously labeled at late-replicating sites with
 
IdU were cultured in fresh medium containing aphidicolin
to collect cells in early S phase. Then, in the continued pres-
ence of aphidicolin, UCN-01, K-252c, or no additional
drug was added. Control cultures were incubated without
any drug (i.e., aphidicolin removed). At indicated times
thereafter, cells were washed free of all drugs, pulse labeled
with CldU, and then fixed and stained with anti-CldU anti-
bodies. The spatial pattern of anti-CldU staining (Fig. 6, B–D),
as well as the percentage of cells stained with CldU (Fig.
6 E) was scored. Control cells released from aphidicolin pro-
ceeded through a normal S phase (Fig. 6 B). When cells
were incubated in the continued presence of both aphidi-
colin and UCN-01, they proceeded through the various pat-
terns of S phase in the absence of DNA synthesis (Fig. 6 C).
In contrast, cells incubated in the continued presence of
aphidicolin and the control K-252c (Fig. 6 D) or in aphidi-
colin alone (Fig. 6 B, 
 
 
 
Aphidicolin/
 
 
 
Drug) remained
poised in early S phase.
To see whether Chk1 regulates the replication timing pro-
gram in cells transiting a normal S phase, we established the
effect of UCN-01 on the timing of progressively later repli-
cating foci in cells in the absence of aphidicolin. Asynchro-
nous CHOC cell cultures were pulse labeled with CldU and
then either treated or not treated with UCN-01. At indi-
cated times after CldU labeling, cells were washed free of
drugs, pulse labeled with IdU, and then fixed and stained for
CldU and IdU. At each time point, the percentage of nuclei
that proceeded from early CldU-labeled replication patterns
to either early, middle, or late IdU replication patterns dur-
ing the chase time was scored (Fig. 7). Progression through
the various patterns of S phase was virtually identical in cells
treated with UCN-01 compared with those not exposed to
the drug. Similarly, in cells synchronized at G1/S with
aphidicolin and released, the presence of UCN-01 did not
advance the timing of the appearance of late patterns (un-
published). Taking the data in Figs. 6 and 7 together, we
conclude that, like 2-aminopurine (2-AP) and caffeine
(Dimitrova and Gilbert, 2000), UCN-01, a selective inhibi-
tor of Chk1, abrogates the intra-S phase checkpoint allow-
ing cells to initiate further replication and progress through
the cell cycle in the absence of DNA replication. In addi-
tion, on release from aphidicolin arrest, cells treated with
UCN-01 are unable to elongate from previously arrested
replication forks, indicating that this checkpoint also main-
tains the integrity of arrested replication forks as shown
previously for caffeine and 2-AP (Dimitrova and Gilbert,
2000). However, abrogation of Chk1 does not affect the
timing of initiation during normal S phase progression.
 
Discussion
 
Here, we present evidence that, in mammalian cells, Chk1
protein kinase plays a role in an intra-S phase checkpoint
controlling late origin firing, which is activated by stalled
but not dynamic replication forks.
Significant phosphorylation and activation of Chk1 oc-
curred when HeLa cells were treated with HU but not with
IR, suggesting an important role for Chk1 specifically in sig-
naling S phase events. In principle, it was conceivable that
Chk1 (and Chk2) might be phosphorylated and activated in
Figure 7.  UCN-01 does not affect the timing of normal S phase 
progression. Three asynchronous CHOC cell cultures were pulse 
labeled for 10 min with CldU. Two of these were then chased 
 / UCN-01. A third culture was incubated in parallel in the 
presence of aphidicolin and UCN-01. At indicated times after CldU 
labeling, aliquots of cells from each were washed free of drugs, 
pulse labeled with IdU for 20 min, and then fixed and stained for 
CldU and IdU. At each time point (minimum of 100 CldU-labeled 
nuclei counted), the percentage of nuclei that proceeded from early 
CldU-labeled replication patterns to either early, middle, or late 
IdU replication patterns during the chase time was scored. The 
percentage of cells that label with IdU decreases as progressively 
more CldU-labeled cells complete S phase and enter G2. Results 
are representative of two independent experiments. 
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an unperturbed S phase and thus the hyperphosphorylation
and activation following HU treatment would be a conse-
quence of cells accumulating in S phase. However, we found
that in synchronized cycling cells, neither Chk1 nor Chk2
was phosphorylated or activated during normal S phase pro-
gression, indicating that activation was not due to the accu-
mulation of S phase cells, but rather a response to replica-
tional stress.
Fusion of S phase cells to late G2 cells has been shown to
delay the appearance of mitotic forms (Rao and Johnson,
1970), which led to the suggestion that ongoing DNA syn-
thesis generates a continuous intrinsic checkpoint signal to
prevent inappropriate entry into mitosis (Dasso and New-
port, 1990). The data presented here indicate that phos-
phorylation and activation of the checkpoint proteins Chk1
and Chk2 are unlikely to be responsible for signaling such an
intrinsic checkpoint. In addition, they strongly suggest that ac-
tivation of these checkpoint elements in mammalian cells
occurs in response to stalled or slowed, but not active, repli-
cation forks. We cannot exclude the possibility that some
other aspect of checkpoint kinase function, not detected in
these studies, participates in signaling an unperturbed S
phase. For example, it remains possible that these kinases are
activated at very specific times in S phase or that small popu-
lations are activated locally. One alternative explanation is
that the presence of G2/M cell cytoplasm in an S phase cell
(Rao and Johnson, 1970) causes replication fork slowing or
stalling, which in turn generates a checkpoint signal.
Chk2 and Chk1 respond differently to DNA structures
that are generated by replication arrest. After release from
replication blocks, Chk1 became rapidly inactivated and in-
activation preceded bulk resumption of DNA synthesis.
This is consistent with the notion that Chk1 activation state
is closely linked to the status of the bulk of cellular replica-
tion forks. However, this is not true for Chk2, which once
activated by replication block, remained so for many hours
in cells released into drug-free media, which resumed and
executed S phase. One possibility is that Chk1 and Chk2
differ in their sensitivity to DNA structures generated by S
phase inhibitors, and Chk2 activation reflects the cellular re-
sponse to a fraction of forks which have not been, or cannot
be, reactivated. Alternatively, Chk2 may respond to a subset
of discrete, aberrant structures, that are insufficient to in-
duce Chk1 activation. Whatever the nature of the struc-
ture(s) that activates Chk2, it does not significantly affect
bulk DNA synthesis, and activation of Chk2 is not sufficient
to block S phase progression. Prolonged activation of Chk2
after synchronization may also underlie the ability of syn-
chronized S phase nuclei to delay M-phase onset (Rao and
Johnson, 1970).
DNA damage incurred in replicating cells results in a
checkpoint-mediated suppression of DNA synthesis. ATM-
deficient cells fail to operate this intra-S phase checkpoint
and carry out significant replication (radio-resistant DNA
synthesis, RDS) even in the presence of DNA damage
(Houldsworth and Lavin, 1980; Painter and Young, 1980).
An additional intra-S phase response is concerned with repli-
cation fork arrest.
 
 
 
This is modulated by a caffeine-sensitive,
ATM-independent checkpoint that operates under condi-
tions of replicational stress, but not during normal S phase
progression (Dimitrova and Gilbert, 2000). The existence of
two S phase checkpoint responses led us to determine
whether the HU-induced activation of Chk1 and Chk2 was
dependent on ATM. We found that Chk1 and Chk2 activa-
tion was retained in ATM-deficient cells treated with HU,
and reintroduction of ATM had no significant effect on the
HU-induced response (unpublished data). Overexpression
of Chk1 in ATM-deficient cells restores the G2 checkpoint
but has no effect on suppressing RDS (Chen et al., 1999).
Taken together, these data indicate that HU-induced activa-
tion of Chk1 and Chk2 represents an intra-S phase check-
point response distinct from that required to suppress RDS
(Falck et al., 2001). The sensitivity of Chk1 and Chk2 acti-
vation to caffeine in conjunction with very recently pub-
lished data suggests that the caffeine-sensitive kinase(s) in-
volved in the HU-induced activation is ATR (Tibbetts et al.,
2000; Zhao and Piwnica-Worms, 2001).
Previous work demonstrated that the replication timing
program controlling origin firing in mammalian cells is reg-
ulated by an ATM-independent, caffeine-sensitive check-
point activated by replication blocks (Dimitrova and Gil-
bert, 2000). Here, we found that treating S phase–arrested
cells with UCN-01 disrupted the Chk1 response, without
any effect on Chk2, and resulted in the initiation of replica-
tion at progressively later-replicating sites as well as in an in-
ability to elongate from previously arrested replication forks.
UCN-01 has also been reported to inhibit at least one other
kinase involved in cell cycle progression, C-TAK1 (Busby et
al., 2000). However, C-TAK1 activity is completely unaf-
fected by treatments that induce or abrogate this S phase
checkpoint (unpublished data) and is very unlikely to be
part of this checkpoint machinery. It is conceivable that
UCN-01 may have other targets that could be involved in
the intra-S phase checkpoint. However, taking together ob-
servations that Chk1 activation occurs only in response to
replication blocks in a caffeine-sensitive and ATM-indepen-
dent manner, and that inactivation of Chk1, but not Chk2,
correlates with resumption of the replication program, the
data presented here provide the first formal link between ab-
rogation of Chk1 function and loss of the intra-S phase
checkpoint controlling both stalled replication fork integrity
and late origin firing. We conclude that, like 2-aminopurine
and caffeine (Dimitrova and Gilbert, 2000), UCN-01 abro-
gates this intra-S phase checkpoint, presumably by interfer-
ing with Chk1-mediated phosphorylation of replication
components allowing cells to initiate further replication and
progress through the cell cycle in the presence of HU. Fur-
ther work will be required to identify such components.
Genetic analysis of this pathway in budding yeast indi-
cates a requirement for the Chk2 homologue, Rad53. In
mammalian cells, Chk2, like Chk1, is activated in an ATM-
independent manner in S phase–arrested cells. It is conceiv-
able that in mammalian cells, suppression of late origin fir-
ing in the presence of HU requires Chk2 in addition to
Chk1. Both proteins are required for the G2 DNA damage
checkpoint, perhaps acting synergistically to induce cycle ar-
rest via the phosphorylation of Cdc25 on Ser216 (Peng et
al., 1997). If Chk2 is involved in this intra-S phase check-
point, then our data indicate that Chk2 activation is not suf-
ficient for its establishment. 
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Finally, in eukaryotic cells, the basis for the timing of rep-
lication origin firing is unknown. In principle, an intra-S
phase checkpoint might influence timing if replication forks
assembled early in S phase generated an inhibitory signal to
prevent the initiation at later-firing origins. We found that
Chk1 (and Chk2) activation only occurred when replica-
tional stress was imposed and no activation could be de-
tected during normal S phase progression. In addition,
blocking Chk1 function in cells either arrested in S phase or
undergoing normal S phase resulted in the initiation of rep-
lication at progressively later replicating sites with a time
course similar to that observed in untreated cells. Taken to-
gether, these observations indicate that the Chk1-mediated
intra-S phase checkpoint functions to arrest a preestablished
replication timing program under conditions of replicational
stress but is unlikely to play a role in the timing of initiation
during normal S phase progression.
 
Materials and methods
 
Reagents, cell lines
 
HeLa (Johnson et al., 1993), AT22IJE-T (Ziv et al., 1997), and CHOC 400
(Dimitrova and Gilbert, 2000) cells were cultured as described. Recombi-
nant wild-type and kinase-dead (D130A) Chk1 proteins were expressed as
GST-fusion proteins in Sf21 insect cells infected with appropriate baculo-
virus and purified as described (Paterson, 1999). Recombinant ATR was ex-
pressed in HEK293 cells and purified as described (Hall-Jackson et al.,
1999).
 
Cell synchronization and treatments
 
In replication arrest experiments, unless otherwise stated, exponential
HeLa cells were treated for 30 min 
 
 
 
 5 mM caffeine and then with 2 mM
hydroxyurea (HU) for 24 h in the continued presence/absence of caffeine.
In irradiation experiments, HeLa cells were treated for 30 min 
 
 
 
/
 
 
 
 5 mM
caffeine and then irradiated (10 Gy) using a 
 
137
 
Cs source (IBL 437C irradia-
tor; CIS UK Ltd)
 
 
 
at 2.9 Gy/min. Cells were then incubated for 1 h 
 
 
 
 caf-
feine. For synchrony experiments, metaphase HeLa cells were obtained as
described (Johnson et al., 1993) using 40 ng/ml nocodozole (Calbiochem)
for 14 h. Cells were then washed and released into normal medium for in-
dicated times.
In checkpoint inhibition experiments, two complementary schemes
were used: (1) Exponential CHOC 400 cells grown on coverslips were
pulse labeled for 10 min with 10
 
 
 
 
 
g/ml CldU (Sigma-Aldrich) and then
treated with 50 
 
 
 
g/ml aphidicolin (Calbiochem) for 12 h 
 
 
 
 300 nM UCN-
01 or 5 
 
 
 
M K-252c. At times after aphidicolin addition, coverslips were
washed with warm PBS, transferred to warm drug-free medium plus 10 
 
 
 
g/
ml IdU (Sigma-Aldrich), and incubated for 20 min; and (2) CHOC 400 mi-
totic cells (95% metaphase) obtained as described (Wu et al., 1997) were
released into drug-free medium for 2 h. Then aphidicolin (5–10 
 
 
 
g/ml) was
added to block cells at G1/S boundary by incubation for another 12–16 h.
The aphidicolin concentration was then raised to 50 
 
 
 
g/ml and cells were
grown in the continued presence/absence of UCN-01 or K-252c. At times
thereafter, up to 12 h, coverslips were transferred to warm drug-free me-
dium containing 10 
 
 
 
g/ml CldU and incubated for 10 min.
 
Cell lysis
 
Cells were lysed in ice cold lysis buffer (LB, 20 mM Tris acetate, pH 7.5,
0.27 M sucrose, 1% Triton X-100, 1 mM EDTA, 1 mM EGTA, 10 mM so-
dium 
 
 
 
-glycerophosphate, 5 mM sodium pyrophosphate, 1 mM sodium
orthovanadate, 50 mM sodium fluoride, 1
 
 
 
 
 
M microcystin, 0.1% 2-mer-
captoethanol, Complete proteinase inhibitor cocktail (Roche). Lysates
were cleared by centrifugation at 16,000 
 
g
 
 for 5 min, frozen in liquid nitro-
gen, and stored at –80
 
 
 
C.
 
Flow cytometry
Cells were trypsinized, washed with PBS, 1 mM EDTA, 1% BSA, resus-
pended in PBS, 1 mM EDTA, and fixed by addition of 10 vol of cold
( 20 C) 70% ethanol and stored at  20 C. Cells were processed and ana-
lyzed on a Becton Dickinson FACScan
® flow cytometer as described (Ball
et al., 1997).
Immunofluorescence microscopy
For BrdU detection, cells grown on coverslips were pulse labeled with 25
 M BrdU for 30 min and then washed with ice-cold PBS, fixed with 4%
paraformaldehyde in PBS for 10 min at 20 C, and permeabilized with PBS
containing 0.2% Triton X-100 for 5 min at 20 C. For CldU and IdU detec-
tion, cells grown on coverslips were washed with PBS, fixed with 4 C 70%
ethanol, and stored at 4 C. The differential staining of DNA sites substi-
tuted with halogenated derivatives of dU was performed essentially as de-
scribed (Dimitrova and Gilbert, 2000).
Antibodies
Sheep polyclonal antibodies against Chk1 were raised against full-length
recombinant human GST-tagged Chk1, and passed over a GST affinity col-
umn before affinity purification on a GST-Chk1 column. Anti-Chk2 anti-
bodies were raised against a COOH-terminal peptide of human Chk2
(Chaturvedi et al., 1999) coupled to keyhole limpet hemocyanin and affin-
ity purified on an immobilized peptide column.
Immunoblotting
Lysates (50  g) were subjected to SDS-PAGE, optimized to resolve modi-
fied forms of Chk1 and Chk2 (acrylamide bisacrylamide ratio of separating
gel was 13.8%:0.4% and 10%:0.1% for Chk1 and Chk2, respectively),
transferred to nitrocellulose, and detected with 1  antibodies using HRP-
conjugated rabbit anti–sheep 2  antibody and enhanced chemilumines-
cence (ECL; Amersham Pharmacia Biotech).
Kinase assays
Chk1 and Chk2 were immunoprecipitated from 150  g of cell lysates us-
ing protein G Sepharose (5  l; Amersham Pharmacia Biotech) conjugated
to 2  g of appropriate antibody. Immunocomplexes were washed twice in
lysis buffer containing 0.5 M NaCl, once in lysis buffer and once in wash
buffer (50 mM Tris-HCl, pH 7.5, 0.1 mM EGTA, 0.1% 2-mercaptoethanol),
and Chk1 and Chk2 activity measured by the ability to phosphorylate a
human Cdc25C-derived peptide Checktide, KKKVSRSGLYRSPSMPENLN-
RPR (Cross and Smythe, 1998). In ATR kinase assays (Hall-Jackson et al.,
1999), sheared salmon sperm DNA was included at 2 ng/ l unless other-
wise indicated.
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